Sanofi-Synthelabo recalls Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Ca
Recalled August 21, 2013 · FDA recall D-886-2013 · Sanofi-Synthelabo
Hazard
Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment. · FDA Class II
Units
998 Bottles
Sold at
Canada
Description
Subpotent Drug: During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.
Product
Rifadin (rifampin) capsules, USP, 150 mg, 100-count capsules per bottle, Manufactured by: Fabrique par Sanofi-Aventis Canada Inc., Laval, Quebec, Canada H7L4A8, DIN # 02091887
Manufacturer(s)
Sanofi-Synthelabo
Made in
Canada
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →